NCT00488072 2026-01-26
Effects of Mirtazapine on Appetite in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
13 trialsNCT05705492 2026-01-21
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT04844970 2025-11-17
Anamorelin Study for Advanced Pancreatic Cancer
Lahey Clinic
Phase 2 Terminated
NCT00489307 2025-11-12
Dexamethasone for Symptom Burden in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03245658 2023-12-18
The Effect of Cannabis in Pancreatic Cancer
University of Copenhagen
Phase 2 Withdrawn
NCT03283488 2023-07-07
Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.
University of Sao Paulo
Phase 2 Completed
NCT05380479 2022-05-18
Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2 Unknown
NCT01503346 2020-02-17
TCM
Changhua Christian Hospital
Phase 2 Completed
NCT00558558 2016-05-13
Haelan and Nutrition in Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01200602 2015-11-25
Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy
Mayo Clinic
Phase 2 Terminated
NCT01501396 2014-02-03
Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite
Washington University School of Medicine
Phase 2 Withdrawn
NCT00379353 2013-02-04
The Effects of Thalidomide on Symptom Clusters
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00316563 2010-02-09
Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
AHS Cancer Control Alberta
Phase 2 Completed